These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20537457)

  • 1. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].
    Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S
    Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
    Ebert W; Muley T; Trainer C; Dienemann H; Drings P
    Anticancer Res; 2002; 22(2B):1083-9. PubMed ID: 12168905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-specific enolase (NSE) serum level in non small cell lung cancer--can it be an indicator of tumour chemosensitivity?
    Zych J; Sakowicz A; Radzikowska E; Załeska J; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():173-8. PubMed ID: 9337535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM; Pujol JL; Grenier J; Daurès JP
    Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A
    Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M
    Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of tumor markers in the management of small cell lung cancer].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):959-65. PubMed ID: 2839115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].
    Zych J; Szturmowicz M; Sakowicz A; Słodkowska J; Załeska M; Radzikowska E; Załeska J; Jodkiewicz Z; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2002; 70(5-6):278-83. PubMed ID: 12518626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
    Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma].
    Hoster M; Kirchheiner T; Rühle KH
    Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.